Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Kritika Sarmah

Is Zoetis Stock Underperforming the Nasdaq?

With a market cap of $77.4 billion, New Jersey-based Zoetis Inc. (ZTS) is the leading animal healthcare company, focusing on livestock and companion animals across various product categories, including vaccines and diagnostics. Catering to cattle, swine, poultry, fish, sheep, dogs, cats, and horses, Zoetis markets directly to veterinarians and livestock producers.

Companies valued at $10 billion or more are generally classified as "large-cap" stocks and Zoetis comfortably fits this criterion, underscoring its strong market presence. Spun off from Pfizer Inc. (PFE) in 2013, the company boasts sustainable growth drivers and opportunities, a diverse and durable portfolio, and a pipeline of medicines, vaccines, diagnostics, and technologies impacting over 100 countries. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.